ABSTRACT
Objective: In this study, we asked whether a possible quantitative or qualitative deficiency in naturally-occurring Foxp3 + CD4
+ regulatory T cells (nT reg ), which display potent inhibitory effects on T cell functions in vitro and in vivo, may predispose to the development of T1D.
Research Design and Methods:
We assessed the frequency and function of Foxp3 + nT reg cells in primary and secondary lymphoid tissues in the NOD animal model of type 1 diabetes.
Results:
We show that the cellular frequency of Foxp3 + nT reg cells in primary and secondary lymphoid tissues is stable and does not decline relative to T1D-resistant mice. We show that thymic and peripheral CD4 + CD25
+ T cells are fully functional in vivo. We also examined the functional impact of CD4 +
Foxp3
+ nT reg cells on the development of autoimmune diabetes, and demonstrate that nT reg cells do not affect the initial priming or expansion of antigen-specific diabetogenic T cells but impact their differentiation in pancreatic lymph nodes (pancLN). Moreover, CD4 +
+ nT reg cells also regulate later events of diabetogenesis by preferentially localizing in the pancreatic environment where they suppress the accumulation and function of effector T cells (T eff ). Finally, we show that the nT reg cell functional potency and intra-pancreatic proliferative potential declines with age, in turn augmenting diabetogenic responses and disease susceptibility.
Conclusion:
This study demonstrates that Foxp3-expressing nT reg cells in NOD mice regulate diabetogenesis, but temporal alterations in nT reg cell function promote immune dysregulation, and the onset of spontaneous autoimmunity.
Functional loss in CD4
+ Foxp3 + Treg cells drives T1D.
INTRODUCTION
NOD mice are characterized by spontaneous development of several autoimmune diseases including T1D, which occurs progressively through a T cell dependent infiltration and destruction of insulin-producing beta (β) islet cells of Langerhans, leading to insulin deficiency(1-4). The extended time interval between establishment of insulitis and onset of disease suggests a progressive loss of peripheral regulatory mechanisms in prediabetic NOD mice prior to disease progression(1). CD4 + naturally-occurring T reg (nT reg ) cells have emerged as the predominant regulatory population mediating peripheral self-tolerance (5-7). The majority of these cells constitutively express the IL-2R α-chain (CD25), and represent 1-10% of thymic or peripheral CD4 + T cells in mice and man(8; 9). Functional abrogation of nT reg cells increases immunity to tumors, allografts and pathogens, and results in the development of multi-organ-specific autoimmunity by an asof-yet undefined mechanism (6). Recent studies show that nT reg cells constitutively and specifically express the Foxp3 transcription factor marker, a critical molecular switch for nT reg cell development and function(10; 11). Targeted deletions or natural mutations of the foxp3 gene leads to a deficiency of nT reg cells, and provokes the development of severe autoimmunity in Scurfy in mice and IPEX patients(10-13).
Several studies have implicated nT reg cells in prevention of T1D. Depletion of CD25-expressing T cells or disruption of the B7/CD28 pathway in NOD mice has been shown to decrease CD4 + CD25
+ nT reg cell frequency, and ultimately leads to an accelerated T1D onset (14; 15). Other studies have correlated T1D resistance in aged NOD mice with the expansion of CD25-expressing CD4 + T cells with regulatory activity within inflamed pancLN(16; 17) . Although T reg cell function has been examined in lymphoid tissues of pre-diabetic and insulitic NOD mice, it is unclear whether these CD4 
RESEARCH DESIGN AND METHODS
Mice. NOD, C57BL/6, NOD.TCRα -/-and NOD.BDC2.5 mice were bred and maintained in pathogen-free conditions at the McGill University animal facility. NOD.TCRα -/-and NOD.BDC2.5 TCR mice were initially a kind gift from Dr. Christophe Benoist (Harvard Univ., Boston, USA).
Phenotypic analysis of CD4
+ T cells. T cells were stained with a variety of fluorochromeconjugated or biotinylated mAbs, as previously described (22;23): anti-CD4 (clone RM5), anti-CD25 (clone PC61.5) (eBioscience, San Diego, CA), anti-Vβ4 (clone CTVB4), anti-CD69 (clone H1.2F3), anti-CD44 (clone IM7), anti-CD62L (clone MEL14) (BD Bioscience, Mississauga, Ontario), and anti-Foxp3 (eBioscience, San Diego, CA). Stained cells were acquired on a FACSCalibur flow cytometer (BD, San Jose, CA). In adoptive transfer experiments, pancreata were digested with collagenase-V (Invitrogen, Burlington, Ont.), and T cells were separated from the digested tissue by centrifugation on a Lympholyte-M gradient (Cederlane), and then stained accordingly.
Purification of CD4
+ T cell subsets. CD4 + T cell subsets were isolated from spleen, thymus or lymph nodes on a FACSAria (BD, San Jose, CA) or AutoMACS (Miltenyi Inc, Auburn, CA) cell sorter as previously described (22; 23). The final purity was assessed on a FACSCalibur (BD, San Jose, CA), and was routinely over 98%. Intracellular cytokine production. Cells from the spleen and pancLN were stimulated 4-5 hr with PMA and ionomycin, and were treated with monensin (2µM) for the last 2-3 hr of culture. After surface staining, cells were fixed and permeabilized, and then intracytoplasmic staining was performed using anti-mouse IL-2 mAb (JES6-5H4), antimouse TNF-α mAb (MP6), anti-mouse 
CD25
-T eff cells from pre-diabetic mice transferred diabetes at a 50% incidence 5-6 wks post-transfer, reaching a total incidence of 80-90% at 10 wks post-transfer (Fig. 1B) . However, when thymic CD4 + CD25 + nT reg cells were co-transferred, T1D onset and incidence were dramatically reduced (Fig. 1B) 
-T eff cells transferred diabetes as early as 11 days post transfer, with an incidence as high as 60-75% at 30 days post-transfer, and correlated with a prominent infiltration of mononuclear cells into the islets and general loss of islet morphology (Fig. 1B-D) . In contrast, the presence of thymic nT reg cells in transferred CD4 + T cells completely abrogated the onset of disease, and protected from T1D for at least 3-4 weeks post-T cell transfer (Fig. 1B) . While not completely preventing the immune cell infiltration of the islets, nT reg cells nonetheless reduced the severity of insulitis, with a greater proportion of islets with preserved morphology (Fig. 1C-D -T cells transferred diabetes at a 50% incidence 5-6 wks post-transfer, reaching an incidence of 80-90% at 10 wks post-transfer ( Fig. 2D ), and correlated with a prominent infiltration of mononuclear cells into the islets and general loss of islet morphology ( Fig. 2E and F) . However, when CD4 + CD25
+ nT reg cells were co-transferred with either prediabetic ( 
-T eff cells, T1D onset and incidence were dramatically reduced at every nT reg /T eff ratio transferred. Moreover, the severity of insulitis was greatly reduced, with a greater proportion of β islets demonstrating preserved morphology ( Fig. 2E and F We reasoned that functional changes in the periphery might nevertheless disrupt nT reg function and precipitate T1D over time. We evaluated the potential for an agedependent variation in nT reg cell suppressor function in our BDC2.5 transfer model. CD4 + CD25
+ T reg cells were isolated from young or adult BDC2.5 mice, and cotransferred with CD4 +
-T eff cells from BDC2.5 mice into NOD.TCRα -/-mice. We show that while nT reg cells from young BDC2.5 mice completely suppressed T1D induced by young or old T eff cells (Fig. 3A) , nT reg cells isolated from older or overtly diabetic BDC2.5 animals were completely ineffective at suppressing T1D induced by young or old T eff cells (Fig. 3A) . It was possible that the lack of regulation of T1D was due to the increased frequency of activated T cells amongst CD4 + T cells. The expression of CD25, CD69, CD44 hi or CD62L lo activation markers on T cells was not significantly different between 3-4 wk and 6-8 wk old donors, and the reduced ability of old Treg cells to control T1D was not due to a reduced proportion of + T cells from overtly diabetic donor mice were completely inefficient in controlling the onset of T1D in our transfer system (Fig.3A) . Furthermore, recipients of 6-8 week old donor CD4 +
-T cells did not demonstrate a higher diabetes incidence compared to 3-4 week old donor cells, excluding the possibility of reduced pathogenicity of younger T eff cells (Fig. 3A) . Interestingly, regulation of T1D could be restored if an additional bolus of purified CD4 + CD25
+ T reg cells from 6-8 week old donor mice were infused in recipient mice (data not shown), suggesting that an increase in the circulating pool of nT reg cells could ultimately control T1D in older NOD mice. Our results do not exclude the possibility that alterations in the pathogenic potential of T eff cells from older -cells was found to be similar in the pancLN and the non-draining LN of both recipients ( Fig. 5A and C) Fig. 5D ), suggesting that nT reg cells actively expand in pancreatic sites.
As altered early T cell priming events cannot directly explain the protective effect of nT reg cells, we then hypothesized that nT reg cells accumulating in pancreatic sites may have a functional impact on T eff cells at later stages of the diabetogenic process. To this end, CD4 + T cell subsets from thymus of BDC2.5 mice were adoptively transferred into NOD.TCRα -/-mice as described above, and 30 days post-transfer the frequency of CD4 + T cells in these sites, compared to recipient mice co-transferred with T eff and nT reg cells (Fig. 6A) . This increased accumulation of T eff cells correlated with the onset of diabetes, and may suggest a role for nT reg cells in the control of antigen-driven recruitment or proliferation of T eff cells in pancreatic sites. Our result show that protection from T1D correlates with a significantly increased proportion of Foxp3 + nT reg cells in these sites, and mirrors the decline in T eff cell numbers suggesting that a crucial part of the protective role of nT reg cells resides in their ability to migrate to or expand in sites of autoimmune attack (Fig. 6A) . While not entirely preventing the infiltration of Foxp3 -T eff cells into the islets, nT reg cells nonetheless reduced the severity of insulitis, with a greater proportion of islets with preserved morphology (Fig. 2E and F) . Interestingly, examination of the few recipient mice receiving only CD4 +
-T eff cells and which never developed T1D revealed that the proportion of Foxp3 + cells were similar to that observed in recipient mice co-injected with thymic nT reg cells, suggesting that this protective Foxp3 + T cell subset originated from the thymic CD25 -T cell donor fraction, and possibly expanded/differentiated within these sites, and ultimately ensure disease protection (Fig. 6A) .
As young and adult nT reg cells differed in their protective effect, we then compared the differential ability of Foxp3 + nT reg cells from 3-4 or 6-8 week old donors to accumulate in inflamed pancreatic sites. In recipients of 3-4 week old cells, the frequency of nT reg cells in pancLN and pancreas was significantly greater than recipients receiving T eff alone and correlated with T1D protection (Fig. 6B and C) . In stark contrast, nT reg cells from 6-8 week old donor mice accumulated less efficiently in the pancLN and pancreas, and correlated with the onset of T1D in the majority of recipient mice ( Fig. 6B and C) . In the few T1D-free mice receiving nT reg cells from 6-8 week old donor mice, we observed that the frequency of nT reg cells in the pancreas was comparable to recipient mice receiving 3-4 week old nT reg cells (Fig. 6C) .
We were unable to find any difference in the homing of nT reg and Teff cells in pancLN over time (data not shown). In order to directly determine whether this reduced frequency of BDC2.5 T reg cells in pancreatic sites was due to a loss of nT reg cell expansion in these sites over time, we examined by FACS the cellular frequency of cycling CD4 +
Foxp3
+ T cells in the periphery of young and old BDC2.5 mice, as determined by the Ki-67 proliferation marker ( Fig. 6D and E) . We show that the total proportion of cycling Foxp3 + T reg cells as well as the fraction of cycling cells amongst the total pool of CD4 +
+ nT reg cells is significantly reduced in pancLN and pancreas of old BDC2.5 mice compared to young mice ( Fig.  6D and E) . Collectively, our results show that nT reg cells expand within inflamed pancreatic sites where they constrict the size of the T eff cell pool and reduce the histopathological consequences of a destructive infiltration. Thus, a possible waning with age of nT reg expansion within pancreatic sites could explain the onset of an uncontrolled T eff cell infiltration of the pancreas and T1D induction. + nT reg cells, irrespective of CD25 expression, represent a stable pool in thymocytes, LN or spleen of neonatal and adult NOD mice, and is comparable to T1D-resistant C57BL/6 mice, thus refuting the view that NOD mice have a developmental defect in nT reg cells. However, it is possible that a functional deficiency in nT reg cells may not be visible as a sudden decline in the frequency of these cells in peripheral tissues, and may conceivably be a resultant to gaps in the TCR repertoire or gene polymorphisms modulating various effector functions(32). Consistently, we show that nT reg cell function wanes with time as evidenced by their inability to expand efficiently and prevent T eff cell infiltration in pancreatic sites, suggesting that the loss of Ag-driven homing or expansion of nT reg cells in pancreatic environments may represent an essential checkpoint in the progression to T1D. We cannot exclude the possibility that timedependent changes in T eff cells may contribute to T1D onset(33).
Discussion
An unresolved question relates to the location of nT reg cell-mediated tolerance induction in vivo. The ability of nT reg cells to localize within tissues to dampen the magnitude of T eff cell responses and prevent the histopathological consequences has been observed in models of infectious disease, IBD and tumors (34; 35). Our results show that nT reg preferentially home and expand within inflamed pancLN and islets of T1D-protected mice, and nT reg cells control the effector functions of infiltrating diabetogenic CD4 + T cells in these sites, albeit not completely preventing insulitis. Interestingly, a more significant reduction in the degree of insulitis was observed with thymic nT reg cells In conclusion, nT reg cells represent a master-switch regulating disease onset and progression in NOD mice, as abrogation of nT reg function can break T cell tolerance to β-islet antigens. Despite nT reg cells actively suppressing anti-islet T cell responses in the neonatal immune system, this suppression is ultimately insufficient to maintain tolerance to pancreatic antigens since autoimmunity ultimately ensues in these mice, as shown in recent studies (46;47). These studies may provide insights into the cellular basis of T1D susceptibility, may lead to the development of novel approaches to potentiate nT reg activity in autoimmune-prone hosts.
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